Multiple Sclerosis Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are between 18 and 70 years old
- People who have already been diagnosed with relapsing-remitting multiple sclerosis (a form of MS where symptoms come and go) before the trial starts
- People whose MS-related physical disability is at or below a certain level, measured by a standard MS scale called the EDSS — the maximum score allowed is 4, which generally means the person can walk without aid (confirm with trial site)
- People who have had their MS diagnosis for no more than 10 years
- People who have health insurance
- People whose MS treatment has either stayed the same or has not changed in the six months before the trial starts — or people who are not on any MS treatment
- People who score 22 or above on a fatigue questionnaire called the FSMC will be placed in the "MS with fatigue" group
- People who score below 22 on the FSMC fatigue questionnaire will be placed in the "MS without fatigue" group
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People for whom an MRI scan is not safe or suitable (for example, those with certain metal implants)
- People who have a known hormonal, immune system, psychiatric, or neurological condition other than relapsing-remitting MS or Major Depressive Disorder
- People who are currently taking certain medications that affect brain chemical systems, such as Levodopa, Amantadine, Fluoxetine, Paroxetine, or antipsychotic medications
- People who have had an MS relapse (a flare-up of symptoms) or have been treated with steroids within the four weeks before the trial starts
- People whose current MS treatment is something other than a B-cell depleting monoclonal antibody or a fumarate medication (confirm with trial site for specific medication names)
- People who have a sleep disorder, as identified by a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chotima Dr. Böttcher, PhD, Max-Delbrück-Centrum Berlin
Phone: +49 30 7560921
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Central fatigue; Neurobehavioral markers of effort discounting; Neurobehavioral markers of habit formation; White matter integrity MRI measure; Brain age marker; Whole-brain grey matter fraction; Whole-brain volume of focal brain lesions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.